GlassScriptPhysician profile
Joey K Hung
NPI 1184079089
$8,688.26
in general payments reported to CMS, 2019-2025
19 companies · $787 in 2025
The $787 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,638 · 2021: $1,176 · 2022: $3,205 · 2023: $238 · 2024: $644 · 2025: $787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,669.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,638.03 | 2020 | |
| Medtronic, INC. | $2,017.29 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $1,117.80 | 2021-2022 | |
| Relievant Medsystems, INC. | $792.39 | 2021-2022 | |
| Painteq LLC | $528.54 | 2022 | |
| Saluda Medical Americas, INC. | $524.63 | 2023-2025 | Evoke, Evoke Scs |
| Nevro Corp. | $321.41 | 2024 | Senza |
| Spr Therapeutics, INC | $251.21 | 2022-2025 | Sprint Pns System |
| Vertos Medical, INC. | $84.36 | 2021-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.35 | 2021-2024 | Relistor |
| Scilex Pharmaceuticals INC. | $71.23 | 2021-2023 | Ztlido |
| Biotronik Nro, INC. | $69.06 | 2025 | Prospera |
| Abbvie INC. | $50.22 | 2024 | |
| Inspire Medical Systems, INC. | $38.27 | 2025 | Inspire |
| Abbott Laboratories | $23.82 | 2025 | Proclaim |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $22.75 | 2025 | Fisher & Paykel Healthcare |
| Pacira Pharmaceuticals Incorporated | $21.23 | 2024 | Exparel, Zilretta, Iovera |
| Merck Sharp & Dohme LLC | $20.98 | 2024 | Bridion |
| Biohaven Pharmaceutical Holding Company LTD. | $17.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joey Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.